| Literature DB >> 6792698 |
A Jung, C van Ouwenaller, A Chantraine, B Courvoisier.
Abstract
Two diphosphonates, EHDP (disodium etidronate, or ethane-hydroxy-diphosphonate) and Cl2MDP (disodium clodronate, or dichloromethylene-diphosphonate) were injected in various doses in 8 patients who had had one or more episodes of malignant hypercalcemia. All patients responded well to the drugs after a time lapse of 2-10 days. Tolerance of the drugs was excellent. EHDP, and especially Cl2MDP, are promising agents for the treatment of hypercalcemia and the inhibition of bone resorption in malignant disorders.Entities:
Mesh：
Substances：
Year: 1980 PMID： 6792698
Source DB: PubMed Journal: Schweiz Med Wochenschr ISSN： 0036-7672